Financials
- Fiscal year
- 2025
- Turnover
- €6.3m
- Loss
- -€1.6m
- Solvency
- 21.2%
Turnover▲ 209%
Net result
20232025
Inbiose
ActiveSummary
Inbiose has been active since 2013 and the Belgian State Gazette contains no insolvency or warning signals. The 2025 annual accounts show equity of €3.6m and a net result of -€1.6m. The figures fluctuate too strongly year-on-year for a reliable trend projection. Its solvency ranks better than 18% of 310 sector peers (fiscal year 2025). The computed 12-month bankruptcy probability is 0.6% (low).
Overview
Activity
Manufacture of chemicals and chemical products
NACE 20590Research and development on biotechnology NACE 72101NACE 72110
1 site
Size
€6.3mturnover 2025
- Staff
- 46.1 FTE
- Equity
- €3.6m
- Loss
- -€1.6m
Structure
- Largest shareholder
- FEDERALE PARTICIPATIE- EN INVESTERINGSMAATSCHAPPIJ · 37.45%
- Board
- 11 members
- Holdings
- 1
Auditor: Baker Tilly BedrijfsrevisorenAccounts 21 d early
Why 70- Loss of €1.6m, the second in a row (FY 2025)- Equity €3.6m (21.2% of total assets)+ Founded in 2013+ Legal form Public limited companyShow the evidence
Checked score
Score 2025
70
/ 100
Healthy
Probability in this band: 0.55% to 1.5%
Better than 51% of its sector peers (NACE 20, small)
Performance against the sector, not lower risk
Financial strength · tick = 2024
Average
Solvency
46+46
equity 21.2% of total assets
Liquidity
54+10
short-term debt 22.6% · cash 9.5%
Profitability
50+50
return on assets -9.3%
Bankruptcy probability, 12 months
0.6%
Low
0%0.5%1.5%4%10%≥ 25%
About 6 in 1,000 comparable companies go bankrupt within 12 months (an estimate).
Last 24 months
11-2024: 2.6%
12-2024: 2.6%▼ -2.0% vs 11-2024
01-2025: 2.6%● 0.0% vs 12-2024
02-2025: 2.6%● 0.0% vs 01-2025
03-2025: 2.7%▲ +5.6% vs 02-2025
04-2025: 2.7%● 0.0% vs 03-2025
05-2025: 2.7%▲ +0.3% vs 04-2025
06-2025: 2.8%▲ +3.1% vs 05-2025
07-2025: 2.9%▲ +4.2% vs 06-2025highest value
08-2025: 2.7%▼ -7.7% vs 07-2025
09-2025: 2.7%● 0.0% vs 08-2025
10-2025: 2.7%● 0.0% vs 09-2025
11-2025: 2.7%● 0.0% vs 10-2025
12-2025: 2.7%● 0.0% vs 11-2025
01-2026: 2.7%● 0.0% vs 12-2025
02-2026: 2.7%● 0.0% vs 01-2026
03-2026: 2.6%▼ -1.9% vs 02-2026
04-2026: 2.6%● 0.0% vs 03-2026
05-2026: 2.6%▲ +0.3% vs 04-2026
06-2026: 2.7%▲ +3.1% vs 05-2026
07-2026: 2.8%▲ +4.0% vs 06-2026
08-2026: 0.6%▼ -79.0% vs 07-2026lowest value
09-2026: 0.6%● 0.0% vs 08-2026lowest value
10-2026: 0.6%● 0.0% vs 09-2026lowest value
- Loss of €1.6m, the second in a row (FY 2025) raises the probability
- Founded in 2013 lowers the probability for this profile
- Equity €3.6m (21.2% of total assets) raises the probability
- Legal form Public limited company lowers the probability
Credit up to €250,000 at 30 days acceptable
Liquidity tight (current ratio 1.49 against 0.74 in 2024; short-term debt: 22.6% and cash: 9.5% of total assets), and 78.8% of the assets are financed with debt.
How it is calculated
The band comes from the bankruptcy probability on a scale of 0 to 100: every 10 points more double the odds of getting through the year without bankruptcy.
| 75-100 | Excellent | under 0.55% |
| 60-74 | Healthy | 0.55% to 1.5% |
| 45-59 | Fair | 1.5% to 4.2% |
| 25-44 | Weak | 4.2% to 15.0% |
| 0-24 | Critical | over 15.0% |
Place inside the band: half the bankruptcy probability, half how the company does against its sector peers (NACE 20, small). Better than this share of them on solvency 18%, liquidity 63%, profitability 22%, growth against the median 99%. That is performance, not lower risk; the band itself always comes from the probability.
Bankruptcy probability: model pd-v3.202610021621, computed on 03-10-2026. The model learns from Belgian bankruptcies and reads the registers, the annual accounts and the gazette.
Ceilings: negative or zero equity, a heavy loss, a special KBO legal situation and a missing filing 59 (two missing 44), an ongoing judicial reorganisation or an ending 24. Financial strength does not count in the score.
Credit check for your own amount and term
Show the recommended maximum : and see how the verdict changes with amount, term and advance.
Signals
Six signals. The signal on the left, the evidence on the right.
−lowers risk+raises risk○neutral
raises risk · Weak solvency vs sector
Solvency (equity / total assets) is in the sector's weakest quartile: better than 18% of 310 sector peers (2025).
NBB · sector comparisonPosition among 310 sector peers
Solvency
better than 18%
← weakest
strongest →
neutral · Latest accounts filed on time
The financial year that closed on 31-12-2025 was due by 31-07-2026 and was filed on 10-07-2026, 21 days ahead of the deadline.
NBB · 10 filingsDeviation from the deadline
2025
21 d early
2024
16 d early
2023
54 d early
2022
38 d early
2021
11 d early
2020
24 d early
2019
51 d early
← before the deadline
after the deadline →
tick = median of all Belgian filingsring = median in the sector
This company filed its last 7 accounts on average 31 days before the deadline; the sector median for financial year 2024 is 22 days before the deadline, and 27% of the sector filed late.
Checked, nothing found (2)
neutral · The next deadline is still running
The next financial year closes on 31-12-2026 and is due by 31-07-2027. Nothing is late today. Usually files around 10 July (4 of the last 5 filed years within 30 days of that day).
Companies Code · seven monthsPosition in the running window
03-10-2026 today31-12-2026 close31-07-2027 deadline
- Reappointment: Baker Tilly Bedrijfsrevisoren (statutory auditor)Permanent representative: Christel De Blander…
- Annual accounts filedfiscal year 2025 · full…
- Resignations: Friday Consulting, Delcourt,Clemence and Dirk…Permanent representatives: Freitag,Barbara and Abeel,Dirk…
Key points
- Risk: 8 loss-making years in a rowloss fiscal year 2025 -€1.6m View
- Positive: Turnover rose in 2025from €2.0m to €6.3m ▲ 209% View
- Caution: Among the weakest 9% on net resultsector median €479,874 · 313 companies -€1.6m View
- Board changedlatest change 22-05-2026 · 11 in office 3 joined · 5 left View
- Positive: Always filed on timeaccounts within the deadline every year 8 years View
- EU research moneyEU contribution €4.3m View
By topic
Board & ownership
- Board
- 11 members
- Largest shareholder
- FEDERALE PARTICIPATIE- EN INVESTERINGSMAATSCHAPPIJ · 37.45%
- Auditor
- Baker Tilly Bedrijfsrevisoren
Go to Board & ownership
Network & group
- Holdings
- 1
- Connected companies
- 39
1 holding
Timeline
- Events
- 35
- Since
- 2013
- Next accounts
- by 31-07-2027
- 11-08-2026Reappointment: Baker Tilly Bedrijfsrevisoren (statutory auditor)
- 10-07-2026Annual accounts filed
- 22-05-2026Resignations: Friday Consulting, Delcourt,Clemence and Dirk Abeel…
Company details
- Sites
- 1
- Legal form
- Public limited company
- Activity
- Manufacture of chemicals and chemical productsNACE 20590
- Founded
- 31-05-2013
- Year ends
- 31-12
- Peppol
- Reachable for e-invoices
Articles of association
- Provisions read
- 26
- Annual meeting
- 25 May at 10:00
- Purpose
- Technologische ontwikkeling,productie en commercialisering van biogebaseerde…
Go further with this company
How much credit can you give this customer, and on what term?Credit check What should you check before you do business with this company?Supplier due diligence Is the workforce growing, and do people stay?Employer check Can you accept this company as a client under the anti-money-laundering law?AML client file Which of your other customers can you e-invoice via Peppol?Peppol check What other support did companies like this one receive, and it did not?Subsidies
Your own company? See how customers, suppliers and banks see it and what to improve first.
Investigating this company? Keep it with today's facts in a case file.